GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » EV-to-EBITDA

SLP (Simulations Plus) EV-to-EBITDA : 50.47 (As of Dec. 12, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Simulations Plus's enterprise value is $595.31 Mil. Simulations Plus's EBITDA for the trailing twelve months (TTM) ended in Aug. 2024 was $11.80 Mil. Therefore, Simulations Plus's EV-to-EBITDA for today is 50.47.

The historical rank and industry rank for Simulations Plus's EV-to-EBITDA or its related term are showing as below:

SLP' s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.42   Med: 42.85   Max: 111.68
Current: 50.47

During the past 13 years, the highest EV-to-EBITDA of Simulations Plus was 111.68. The lowest was 12.42. And the median was 42.85.

SLP's EV-to-EBITDA is ranked worse than
89.19% of 481 companies
in the Healthcare Providers & Services industry
Industry Median: 12.32 vs SLP: 50.47

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-12), Simulations Plus's stock price is $30.625. Simulations Plus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was $0.490. Therefore, Simulations Plus's PE Ratio (TTM) for today is 62.50.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Simulations Plus EV-to-EBITDA Historical Data

The historical data trend for Simulations Plus's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus EV-to-EBITDA Chart

Simulations Plus Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.71 52.39 58.96 61.50 59.99

Simulations Plus Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.50 52.27 53.90 73.70 59.99

Competitive Comparison of Simulations Plus's EV-to-EBITDA

For the Health Information Services subindustry, Simulations Plus's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Simulations Plus's EV-to-EBITDA falls into.



Simulations Plus EV-to-EBITDA Calculation

Simulations Plus's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=595.309/11.796
=50.47

Simulations Plus's current Enterprise Value is $595.31 Mil.
Simulations Plus's EBITDA for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus  (NAS:SLP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Simulations Plus's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=30.625/0.490
=62.50

Simulations Plus's share price for today is $30.625.
Simulations Plus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.490.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Simulations Plus EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Simulations Plus's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Executives
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221